Pharmaceutical firms’ sales forecast positive from 4Q

Published: 2012-05-23 06:58:00

Updated: 2012-05-23 06:58:00

Local domestic companies’ sales are likely to regain their momentum from the fourth quarter thanks much to effects of new drugs launched during the January-March period, according to a local expert.

According to Hana Daetoo Securites, the fourth-quarter revenues of Korean drug makers in the ph...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK